Ono Pharmaceutical Co., Ltd. (TYO:4528)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Business	515.79B	486.87B	502.67B	447.19B	361.36B
Total	515.79B	486.87B	502.67B	447.19B	361.36B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	287.09B	295.25B	308.23B	288.16B	241.97B
Americas	197.06B	167.05B	158.93B	142.79B	105.89B
Asia	17.72B	16.34B	21.93B	11.63B	8.90B
Europe	12.32B	7.50B	13.59B	4.62B	4.61B
Others	1.60B	729.00M	-	-	-
Total	515.78B	486.87B	502.67B	447.19B	361.36B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error